Bitwise MARA Option Income Strategy ETF SEC Filings

Welcome to our dedicated page for Bitwise MARA Option Income Strategy ETF SEC filings (Ticker: IMRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The IMRA SEC filings page on Stock Titan provides a view into the regulatory record associated with the IMRA ticker and its corporate history. IMRA is identified as Bitwise MARA Option Income Strategy ETF, and the symbol has also been historically linked to Imara Inc., which later merged with Enliven Therapeutics, Inc. For investors and researchers, understanding this evolution is important when reviewing filings and related documents.

Historical Imara filings, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K referenced in company news releases, contain detailed disclosures about Imara’s clinical-stage biotechnology activities. These documents describe programs including tovinontrine (IMR-687), a PDE9 inhibitor in Phase 2b clinical trials for sickle cell disease and beta-thalassemia and in development for heart failure with preserved ejection fraction, and IMR-261, an oral Nrf2 activator with preclinical data in hemoglobin and iron overload-related disorders. They also discuss clinical trial design, risk factors, and other regulatory information.

Merger-related filings, including a registration statement on Form S-4 referenced in the merger announcements, outline the terms of the all-stock transaction between Imara and Enliven Therapeutics, Inc., the planned issuance of shares, and the subsequent renaming of the combined company to Enliven Therapeutics, Inc. Later, an 8-K filing excerpt shows Enliven Therapeutics, Inc. as the registrant with common stock listed on the Nasdaq Global Select Market under the symbol ELVN, and includes information about matters submitted to a vote of stockholders.

On Stock Titan, users can access these types of filings and benefit from AI-powered summaries that explain key points in plain language, highlight material events, and help interpret complex sections in documents such as 10-Ks, 10-Qs, 8-Ks, proxy statements, and other forms. For symbols with a history like IMRA, this can clarify how earlier Imara disclosures connect to the current Enliven Therapeutics, Inc. listing under ELVN and to the separate identification of IMRA as Bitwise MARA Option Income Strategy ETF.